$TRVI

Trevi Therapeutics, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · New Haven, CT

TRVI chart

What traders are saying about $TRVI

Latest posts

Trevi Therapeutics, Inc. news

Trevi Therapeutics, Inc. key financials

USD2025202420232022
Net income-$42.8M-$47.9M-$29.1M-$29.2M
Diluted EPS$-0.32$-0.47$-0.29$-0.45
Total assets (year end)$193.4M$110.9M$89.4M$123.0M
Cash and equivalents (year end)$18.9M$34.1M$32.4M$12.6M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Trevi Therapeutics, Inc.

Ticker
TRVI (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
New Haven, CT
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1563880

Frequently asked questions

What exchange is Trevi Therapeutics, Inc. listed on?

Trevi Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TRVI.

What industry is Trevi Therapeutics, Inc. in?

Trevi Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Trevi Therapeutics, Inc. headquartered?

Trevi Therapeutics, Inc.'s business address on file with the SEC is in New Haven, CT.

When does Trevi Therapeutics, Inc.'s fiscal year end?

Trevi Therapeutics, Inc.'s fiscal year ends on December 31.